Lee Jun Hee, Won Jong Yun, Kim Ji Eon, Kim Hee Jung, Jung Jae Seung, Son Ho Sung
Department of Thoracic and Cardiovascular Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
J Chest Surg. 2021 Feb 5;54(1):36-44. doi: 10.5090/kjtcs.20.123.
Extracorporeal membrane oxygenation (ECMO) has become increasingly accepted as a life-saving procedure for patients with severe acute respiratory distress syndrome (ARDS). This study investigated the relationship between cumulative fluid balance (CFB) and outcomes in adult ARDS patients treated with ECMO.
We retrospectively analyzed the data of adult ARDS patients who received ECMO between December 2009 and December 2019 at Korea University Anam Hospital. CFB was calculated during the first 7 days after ECMO initiation. The primary endpoint was 28-day mortality.
The 74 patients were divided into survivor (n=33) and non-survivor (n=41) groups based on 28-day survival. Non-survivors showed a significantly higher CFB at 1-7 days (p<0.05). Cox multivariable proportional hazard regression revealed a relationship between CFB on day 3 and 28-day mortality (hazard ratio, 3.366; 95% confidence interval, 1.528-7.417; p=0.003).
In adult ARDS patients treated with ECMO, a higher positive CFB on day 3 was associated with increased 28-day mortality. Based on our findings, we suggest a restrictive fluid strategy in ARDS patients treated with ECMO. CFB may be a useful predictor of survival in ARDS patients treated with ECMO.
体外膜肺氧合(ECMO)已越来越被视为治疗严重急性呼吸窘迫综合征(ARDS)患者的一种挽救生命的方法。本研究调查了接受ECMO治疗的成年ARDS患者的累积液体平衡(CFB)与预后之间的关系。
我们回顾性分析了2009年12月至2019年12月在韩国大学安岩医院接受ECMO治疗的成年ARDS患者的数据。在开始ECMO治疗后的前7天计算CFB。主要终点是28天死亡率。
根据28天生存率,74例患者被分为存活组(n = 33)和非存活组(n = 41)。非存活组在第1 - 7天的CFB显著更高(p < 0.05)。Cox多变量比例风险回归显示第3天的CFB与28天死亡率之间存在关联(风险比,3.366;95%置信区间,1.528 - 7.417;p = 0.003)。
在接受ECMO治疗的成年ARDS患者中,第3天较高的正CFB与28天死亡率增加相关。基于我们的研究结果,我们建议对接受ECMO治疗的ARDS患者采取限制性液体策略。CFB可能是接受ECMO治疗的ARDS患者生存的有用预测指标。